U.S. markets open in 6 hours 36 minutes

Brainstorm Cell Therapeutics Inc. (BCLI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.5100-0.1400 (-3.84%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 4/12/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 0.08
52-Week Change 3-35.96%
S&P500 52-Week Change 345.07%
52 Week High 317.9500
52 Week Low 33.1000
50-Day Moving Average 33.9376
200-Day Moving Average 37.2187

Share Statistics

Avg Vol (3 month) 31.21M
Avg Vol (10 day) 3373.46k
Shares Outstanding 535.72M
Implied Shares Outstanding 6N/A
Float 31.54M
% Held by Insiders 118.19%
% Held by Institutions 123.13%
Shares Short (Mar 14, 2021) 44.22M
Short Ratio (Mar 14, 2021) 43.77
Short % of Float (Mar 14, 2021) 413.64%
Short % of Shares Outstanding (Mar 14, 2021) 411.81%
Shares Short (prior month Feb 11, 2021) 44.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Sep 15, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-68.53%
Return on Equity (ttm)-273.75%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -31.46M
Net Income Avi to Common (ttm)-31.81M
Diluted EPS (ttm)-1.0660
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)41.94M
Total Cash Per Share (mrq)1.17
Total Debt (mrq)7.22M
Total Debt/Equity (mrq)20.35
Current Ratio (mrq)3.85
Book Value Per Share (mrq)1.01

Cash Flow Statement

Operating Cash Flow (ttm)-35.19M
Levered Free Cash Flow (ttm)-23.81M